Xiaoqi Liu, an assistant professor of Biochemistry, has claimed that an overabundance of the polo-like kinase 1 (Plk1) molecule during cell growth, as well as a shortage of the p53 molecule, could lead to tumour formation.
Laboratory experiments have revealed that the Plk1 molecule indirectly attacks p53 in a process called ubiquitination.
“This provides the mechanism for how p53 loses its function in cancer cells. If we understand how the cancer forms, then we can create a more useful therapeutic approach to treating that cancer,” said Liu.
At the time of cell growth, Plk1 uses its protein kinase activity called phosphorylation, which consists of adding a phosphate group to a protein called Topors, which binds itself to p53 molecules during the ubiquitination process.
Phosphorylation is basically an instruction from Plk1 to increase its ubiquitination activity, which kills p53 molecules.
According to Liu, p53 could be thought of as a protective force, which when gets destroyed by Topors, makes Plk1 stronger, allowing the cells to become cancerous.
“We’re trying to understand how p53 is regulated. We want to keep p53 as normal as possible. In about 50 percent of cancers, p53 had lost its function, and there was too much Plk1. Since Plk1 is overexpressed in cancers, it is a cancer therapy target,” said Liu.
Topors can also carry out a function called sumoylation, in which Topors binds to p53 molecules and creates more p53.
Liu could force cells in his lab to go through the ubiquitination or sumoylation process to show how p53 molecules were affected.
However, he said that they were still unclear as to why the Plk1 molecule chooses to initiate ubiquitination over sumoylation.
Liu said that the next step in the research would be to test different Plk1 inhibitors to see how they affect the phosphorylation process.
The study has been published in the early online publication of the Journal of Biological Chemistry. (ANI)
Filed under Cancer, News
Related?New mechanism controlling tumour growth in the brain uncoveredJune 9th, 2009 WASHINGTON - In what may become a new drug target for metastatic brain cancer, scientists from The Scripps Research Institute have discovered a molecular mechanism that plays a pivotal role in controlling cancer growth in the brain. "Our study could have a broad impact because it explains at a molecular level how metastatic lesions thrive in the brain. Blood protein may hold key to stopping cancer progressionApril 1st, 2009 WASHINGTON - Scientists at Wake Forest University School of Medicine have reached a step closer to developing a new drug to inhibit tumour growth in cancer patients, and potentially help in the healing of wounds. The researchers looked at angiogenesis - the body's formation of new blood vessels from existing blood vessels - and how some blood proteins are involved in that process and affect blood vessel growth during a study. Stem-Cells Can Regulates the Mechanism of the Production of New CellsJune 16th, 2006 Researchers at Karolinska Institutet have identified an important mechanism that regulates how many new cells are produced by each intestinal stem cell.
It has long been known that the new cells are often formed by immature cells known as stem cells, but the mechanism regulating the number of new cells produced has remained something of [...]Scientists identify waste disposal protein that is key to cancer tumour suppressionJune 12th, 2009 WASHINGTON - American scientists have identified a waste disposal protein, which is key to cancer tumour suppression in a process known as autophagy, in which cancer cells eat themselves. The finding attains significance because it may for the first time help scientists' understand the mechanism that makes autophagy a pathway to cancer tumour suppression. Scientists identify triggering mechanism behind the start of breast, prostate cancerMarch 17th, 2009 WASHINGTON - Scientists in America have identified the triggering mechanism by which breast and prostate cancer cells begin. Dr. Ercole Cavalieri and Dr. Researchers isolate molecular mechanism that spurs cancer growthDecember 31st, 2008 LONDON - Researchers have identified a molecular mechanism that spurs growth of cancer cells by protecting them from chemotherapy. Both the messenger substance nitrogen monoxide (NO) and the protein 'survivin' play a role in this process. Tumour suppressing gene key to ovarian cancer regenerationJanuary 2nd, 2009 WASHINGTON - A single tumour-suppressing gene is a key to unravel how dormant ovarian cancer cells that persist after initial treatment, to reawaken years later, according to a new study. The study found that expression of a gene called ARHI (aplasia Ras homolog member I) acts as a switch for autophagy, or self-cannibalisation, in ovarian cancer cells. Hormone therapy may make prostate tumours more aggressiveJune 11th, 2009 WASHINGTON - Researchers have found that although hormone therapy helps prevent growth of the prostate cancer, the treatment also changes its properties, thereby making the tumour more aggressive. The new study from Sahlgrenska Academy showed that though treatment prevents growth of the tumour, it might make tumour more aggressive and more liable to form metastases.
Key mechanism behind tumour formation identified
View this post on my blog: http://diseasecancer.net/key-mechanism-behind-tumour-formation-identified
0 comments:
Post a Comment